Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.

Mugusi SF, Ngaimisi E, Janabi MY, Mugusi FM, Minzi OM, Sasi PG, Bakari M, Lindquist L, Aklillu E, Sandstrom EG.

Antivir Ther. 2012;17(2):265-74. doi: 10.3851/IMP1956. Epub 2011 Nov 17.

PMID:
22293579
[PubMed - indexed for MEDLINE]
2.

Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania.

Bwana V, Tenu F, Magesa SM, Mfinanga SG.

Tanzan J Health Res. 2011 Jan;13(1):14-20.

PMID:
24409642
[PubMed - indexed for MEDLINE]
3.

Wasting and body composition of adults with pulmonary tuberculosis in relation to HIV-1 coinfection, socioeconomic status, and severity of tuberculosis.

Villamor E, Saathoff E, Mugusi F, Bosch RJ, Urassa W, Fawzi WW.

Eur J Clin Nutr. 2006 Feb;60(2):163-71.

PMID:
16234841
[PubMed - indexed for MEDLINE]
4.

Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania.

Mugusi S, Ngaimisi E, Janabi M, Minzi O, Bakari M, Riedel KD, Burhenne J, Lindquist L, Mugusi F, Sandstrom E, Aklillu E.

PLoS One. 2012;7(7):e40180. doi: 10.1371/journal.pone.0040180. Epub 2012 Jul 11.

PMID:
22808112
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.

Schmaltz CA, Santoro-Lopes G, Lourenço MC, Morgado MG, Velasque Lde S, Rolla VC.

PLoS One. 2012;7(9):e45704. doi: 10.1371/journal.pone.0045704. Epub 2012 Sep 25.

PMID:
23049842
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.

Kassa A, Teka A, Shewaamare A, Jerene D.

Trans R Soc Trop Med Hyg. 2012 Jun;106(6):363-70. doi: 10.1016/j.trstmh.2012.03.002. Epub 2012 Apr 20.

PMID:
22521216
[PubMed - indexed for MEDLINE]
7.

Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.

Siika AM, Yiannoutsos CT, Wools-Kaloustian KK, Musick BS, Mwangi AW, Diero LO, Kimaiyo SN, Tierney WM, Carter JE.

PLoS One. 2013;8(1):e53022. doi: 10.1371/journal.pone.0053022. Epub 2013 Jan 2.

PMID:
23301015
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Body mass index and risk of tuberculosis and death.

Hanrahan CF, Golub JE, Mohapi L, Tshabangu N, Modisenyane T, Chaisson RE, Gray GE, McIntyre JA, Martinson NA.

AIDS. 2010 Jun 19;24(10):1501-8. doi: 10.1097/QAD.0b013e32833a2a4a.

PMID:
20505496
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007.

Taarnhøj GA, Engsig FN, Ravn P, Johansen IS, Larsen CS, Røge B, Andersen AB, Obel N.

BMC Pulm Med. 2011 May 23;11:26. doi: 10.1186/1471-2466-11-26.

PMID:
21605366
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.

Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC.

AIDS. 2003 Dec 5;17(18):2615-22.

PMID:
14685055
[PubMed - indexed for MEDLINE]
11.

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL.

AIDS. 2002 Jan 4;16(1):75-83.

PMID:
11741165
[PubMed - indexed for MEDLINE]
12.

Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients.

Kwara A, Carter EJ, Rich JD, Flanigan TP.

AIDS Patient Care STDS. 2004 Jun;18(6):341-7.

PMID:
15294084
[PubMed - indexed for MEDLINE]
13.

Safety and antiretroviral effectiveness of concomitant use of rifampicin and efavirenz for antiretroviral-naive patients in India who are coinfected with tuberculosis and HIV-1.

Patel A, Patel K, Patel J, Shah N, Patel B, Rani S.

J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1166-9.

PMID:
15319677
[PubMed - indexed for MEDLINE]
14.

Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.

Kabali C, von Reyn CF, Brooks DR, Waddell R, Mtei L, Bakari M, Matee M, Pallangyo K, Arbeit RD, Horsburgh CR Jr.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1515-21, i. doi: 10.5588/ijtld.10.0788.

PMID:
22008766
[PubMed - indexed for MEDLINE]
15.

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.

Lawn SD, Badri M, Wood R.

AIDS. 2005 Dec 2;19(18):2109-16.

PMID:
16284460
[PubMed - indexed for MEDLINE]
16.

Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis.

Mugusi FM, Mehta S, Villamor E, Urassa W, Saathoff E, Bosch RJ, Fawzi WW.

BMC Public Health. 2009 Nov 12;9:409. doi: 10.1186/1471-2458-9-409.

PMID:
19909501
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?

Pettit AC, Jenkins CA, Stinnette SE, Rebeiro PF, Blackwell RB, Raffanti SP, Shepherd BE, Sterling TR.

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):305-10. doi: 10.1097/QAI.0b013e3182182e2d.

PMID:
21423024
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.

Manosuthi W, Mankatitham W, Lueangniyomkul A, Thongyen S, Likanonsakul S, Suwanvattana P, Thawornwan U, Suntisuklappon B, Nilkamhang S, Sungkanuparph S; TIME Study Team.

J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):377-83. doi: 10.1097/QAI.0b013e31825b5e06.

PMID:
22592586
[PubMed - indexed for MEDLINE]
19.

Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment.

Ku NS, Oh JO, Shin SY, Kim SB, Kim HW, Jeong SJ, Han SH, Song YG, Kim JM, Choi JY.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):226-30. doi: 10.1089/AID.2012.0192. Epub 2012 Sep 11.

PMID:
22881387
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Test characteristics of urinary lipoarabinomannan and predictors of mortality among hospitalized HIV-infected tuberculosis suspects in Tanzania.

Talbot E, Munseri P, Teixeira P, Matee M, Bakari M, Lahey T, von Reyn F.

PLoS One. 2012;7(3):e32876. doi: 10.1371/journal.pone.0032876. Epub 2012 Mar 8.

PMID:
22412939
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk